Erratum to: mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer (Journal of Cellular Physiology, (2012), 227, 5, (1805–1813), 10.1002/jcp.22904);MDA-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer

Journal of Cellular Physiology

Volumn 227, Issue 5, 2012, Pages 1805-1813

  Bhutia, Sujit K ^a,g   Das, Swadesh K ^a   Kegelman, Timothy P ^a   Azab, Belal ^a   Dash, Rupesh ^a   Su, Zhao Zhong ^a   Wang, Xiang Yang ^a,b   Rizzi, Federica ^c   Bettuzzi, Saverio ^c   Lee, Seok Geun ^d   Dent, Paul ^a,b   Grant, Steven ^b,e   Curiel, David T ^f   Sarkar, Devanand ^a,b   Fisher, Paul B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF PARMA   (Italy)

^d Kyung Hee University   (South Korea)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; INTERLEUKIN 24;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL MIGRATION; CELL NUCLEUS; CELL PROTECTION; CELL VIABILITY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN INTERACTION;

EID: 84862907928     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.28004     Document Type: Erratum

References (48)

1. Bettuzzi S, Hiipakka RA, Gilna P, Liao ST. 1989. Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem J 257: 293-296.
2. Bettuzzi S, Davalli P, Astancolle S, Carani C, Madeo B, Tampieri A, Corti A. 2000. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulphated glycoprotein2) in human prostate cancer specimens. Cancer Res 60: 28-34.
3. Bhutia SK, Dash R, Das SK, Azab B, Su ZZ, Lee SG, Grant S, Yacoub A, Dent P, Curiel DT, Sarkar D, Fisher PB. 2010. Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24. Cancer Res 70: 3667-3676.
4. Bhutia SK, Das SK, Azab B, Dash R, Su ZZ, Lee SG, Dent P, Curiel DT, Sarkar D, Fisher PB. 2011. Autophagy switches to apoptosis in prostate cancer cells infected with melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24). Autophagy 7.
5. Caporali A, Davalli P, Astancolle S, D'Arca D, Brausi M, Bettuzzi S, Corti A. 2004. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin. Carcinogenesis 25: 2217-2224.
6. Cunningham CC, Chada S, Merritt JA, Tong A, Senzer N, Zhang Y, Mhashilkar A, Parker K, Vukelja S, Richards D, Hood J, Coffee K, Nemunaitis J. 2005. Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: A phase I study. Mol Ther 11: 149-159.
7. Dash R, Richards JE, Su ZZ, Bhutia SK, Azab B, Rahmani M, Dasmahapatra G, Yacoub A, Dent P, Dmitriev IP, Curiel DT, Grant S, Pellecchia M, Reed JC, Sarkar D, Fisher PB. 2010. Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokine. Cancer Res 70: 5034-5045.
8. Dash R, Bhutia SK, Azab B, Su ZZ, Quinn BA, Kegelmen TP, Das SK, Kim K, Lee SG, Park MA, Yacoub A, Rahmani M, Emdad L, Dmitriev IP, Wang XY, Sarkar D, Grant S, Dent P, Curiel DT, Fisher PB. 2011. mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-specific toxicity. Cytokine Growth Factor Rev 21: 381-391.
9. Fisher PB. 2005. Is mda-7/IL-24 a "magic bullet" for cancer? Cancer Res 65: 10128-10138.
10. Fisher PB, Gopalkrishnan RV, Chada S, Ramesh R, Grimm EA, Rosenfeld MR, Curiel DT, Dent P. 2003. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: From the laboratory into the clinic. Cancer Biol Ther 2: S23-S37.
11. Gao P, Sun X, Chen X, Wang Y, Foster BA, Subjeck J, Fisher PB, Wang XY. 2008. Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24. Cancer Res 68: 3890-3898.
12. Gleave M, Miyake H. 2005. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer. World J Urol 23: 38-46.
13. Gleave ME, Miyake H, Zellweger T, Chi K, July L, Nelson C, Rennie P. 2001. Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer. Urology 58: 39-49.
14. Gupta P, Walter MR, Su ZZ, Lebedeva IV, Emdad L, Randolph A, Valerie K, Sarkar D, Fisher PB. 2006. BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis. Cancer Res 66: 8182-8191.
15. Hara I, Miyake H, Gleave ME, Kamidono S. 2001. Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo. Jpn J Cancer Res 92: 1220-1224.
16. Hoeller C, Pratscher B, Thallinger C, Winter D, Fink D, Kovacic B, Sexl V, Wacheck V, Gleave ME, Pehamberger H, Jansen B. 2005. Clusterin regulates drug-resistance in melanoma cells. J Invest Dermatol 124: 1300-1307.
17. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. 1995. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11: 2477-2486.
18. Jones SE, Jomary C. 2002. Clusterin. Int J Biochem Cell Biol 34: 427-431.
19. July LV, Akbari M, Zellwegger T, Jones EC, Goldenberg SL, Gleave ME. 2002. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate 50: 179-188.
20. Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B. 2005. Gonadotropin releasing hormone agonists in the treatment of prostate cancer. Endocr Rev 26: 361-379.
21. Lebedeva IV, Emdad L, Su ZZ, Gupta P, Sauane M, Sarkar D, Staudt MR, Liu SJ, Taher MM, Xiao R, Barral P, Lee SG, Wang D, Vozhilla N, Park ES, Chatman L, Boukerche H, Ramesh R, Inoue S, Chada S, Li R, De Pass AL, Mahasreshti PJ, Dmitriev IP, Curiel DT, Yacoub A, Grant S, Dent P, Senzer N, Nemunaitis JJ, Fisher PB. 2007. mda-7/IL-24, novel anticancer cytokine: fOcus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience. Int J Oncol 31: 985-1007.
22. Lee ECY, Tenniswood MPR. 2004. Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapy. J Cell Biochem 91: 662-670.
23. Lee CH, Jin RJ, Kwak C, Jeong H, Park MS, Lee NK, Lee SE. 2002. Suppression of clusterin expression enhanced cisplatin-induced cytotoxicity on renal cell carcinoma cells. Urology 60: 516-520.
24. Leskov K, Klokov D, Li J, Kinsella TJ, Boothman DA. 2003. Synthesis and functional analyses of nuclear clusterin: A cell death protein. J Biol Chem 278: 11590-11600.
25. Miyahara R, Banerjee S, Kawano K, Efferson C, Tsuda N, Miyahara Y, Ioannides CG, Chada S, Ramesh R. 2006. Melanoma differentiation associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model. Cancer Gene Ther 13: 753-761.
26. Moretti RM, Marelli MM, Mai S, Cariboni A, Scaltriti M, Bettuzzi S, Limonta P. 2007. Clusterin isoforms differentially affect growth and motility of prostate cells: Possible implications in prostate tumorigenesis. Cancer Res 67: 10325-10333.
27. Nelen V. 2007. Epidemiology of prostate cancer. Recent Results Cancer Res 175: 1-8.
28. Orlandi A, Pucci S, Ciucci A, Pichiorri F, Ferlosio A, Spagnoli LG. 2005. Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells. Arterioscler Thromb Vasc Biol 25: 348-353.
29. Park DC, Yeo SG, Wilson MR, Yerbury JJ, Kwong J, Welch WR, Choi YK, Birrer MJ, Mok SC, Wong KK. 2008a. Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer. Neoplasia 10: 964-972.
30. Park MA, Yacoub A, Sarkar D, Emdad L, Rahmani M, Spiegel S, Koumenis C, Graf M, Curiel DT, Grant S, Fisher PB, Dent P. 2008b. PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells. Autophagy 4: 513-515.
31. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. 2004. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22: 929-979.
32. Purrello M, Bettuzzi S, Di Pietro C, Mirabile E, Di Blasi M, Rimini R, Grzeschik KH, Ingletti C, Corti A, Sichel G. 1991. The gene for SP-40, 40, human homolog of rat sulphated glycoprotein 2, rat clusterin, and testosterone-repressed prostate message 2, maps to chromosome 8. Genomics 10: 151-156.
33. Ramesh R, Mhashilkar AM, Tanaka F, Saito Y, Branch CD, Sieger K, Mumm JB, Stewart AL, Boquoi A, Dumoutier L, Grimm EA, Renauld JC, Kotenko S, Chada S. 2003. Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor. Cancer Res 63: 5105-5113.
34. Rosenberg ME, Silkensen J. 1995. Clusterin: Physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27: 633-645.
35. Sarkar D, Lebedeva IV, Gupta P, Emdad L, Sauane M, Dent P, Curiel DT, Fisher PB. 2007. Melanoma differentiation associated gene-7 (mda-7)/IL-24: A 'magic bullet' for cancer therapy? Expert Opin Biol Ther 7: 577-586.
36. Sauane M, Su ZZ, Gupta P, Lebedeva IV, Dent P, Sarkar D, Fisher PB. 2008. Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis. Proc Natl Acad Sci USA 105: 9763-9768.
37. Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, Corti A, Bettuzzi S. 2004a. Clusterin (SGP-2, ApoJ) expression is down-regulated in low- and high grade human prostate cancer. Int J Cancer 108: 23-30.
38. Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S. 2004b. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells. Cancer Res 64: 6174-6182.
39. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J. 2006. Challenge and promise: Roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13: 12-19.
40. So A, Sinnemann S, Huntsman D, Fazli L, Gleave ME. 2005. Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol Cancer Ther 4: 1837-1849.
41. Springate CM, Jackson JK, Gleave ME, Burt HM. 2005. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. Cancer Chemother Pharmacol 56: 239-247.
42. Su Z, Emdad L, Sauane M, Lebedeva IV, Sarkar D, Gupta P, James CD, Randolph A, Valerie K, Walter MR, Dent P, Fisher PB. 2005. Unique aspects of mda-7/IL-24 antitumor bystander activity: Establishing a role for secretion of MDA-7/IL-24 protein by normal cells. Oncogene 24: 7552-7566.
43. Su ZZ, Lebedeva IV, Sarkar D, Emdad L, Gupta P, Kitada S, Dent P, Reed JC, Fisher PB. 2006. Ionizing radiation enhances therapeutic activity of mda-7/IL-24: Overcoming radiation- and mda-7/ IL-24-resistance in prostate cancer cells overexpressing the antiapoptotic proteins bcl-xL or bcl-2. Oncogene 25: 2339-2348.
44. Tong AW, Nemunaitis J, Su D, Zhang Y, Cunningham C, Senzer N, Netto G, Rich D, Mhashilkar A, Parker K, Coffee K, Ramesh R, Ekmekcioglu S, Grimm EA, van Wart Hood J, Merritt J, Chada S. 2005. Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanomadifferentiation associated gene- 7 (mda-7/IL24): Biologic outcome in advanced cancer patients. Mol Ther 11: 160-172.
45. Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES. 2004. Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 64: 1834-1842.
46. Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos EF. 2005. Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Rad Biol Med 38: 436-449.
47. Yacoub A, Hamed H, Emdad L, Dos Santos W, Gupta P, Broaddus WC, Ramakrishnan V, Sarkar D, Shah K, Curiel DT, Grant S, Fisher PB, Dent P. 2008. MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors. Cancer Biol Ther 7: 917-933.
48. Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, Boothman DA. 2000. Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death. Nucleic Acid Res 97: 5907-5912.